Aurobindo Pharma(AUROPHARMA)
India - HyderabadPharmaceutical
Focus: Aurobindo Pharma is a large-scale generic and specialty pharmaceutical manufacturer headquartered in Hyderabad, India, with 10,000+ employees and a public listing on NSE/BSE. The company focuses primarily on off-patent oral and injectable medications for global markets, particularly the US.
Profile data last refreshed 12h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Employees
10001+
Open Jobs
0
About Aurobindo Pharma
AI assessmentNot HiringNo open roles listed right now. Follow Aurobindo Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
1 imminent
VERSACLOZ
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$22M Part DDeclining
Post-LOE
Dominant revenue driver (18% of company total) but mature generic with no patent protection, facing sustained competitive pricing pressure.
Help build intelligence for Aurobindo Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.